Optimer Pharmaceuticals (OPTR)
Optimer Pharmaceuticals Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | -11.20M | 12.82M | -26.81M | -24.92M | 44.84M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 0.1735M | 0.1708M | 0.1478M | 0.1204M | 0.086M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | -20.19M | 4.919M | 2.693M | 2.925M | 4.556M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Non-Cash Items | -20.02M | 5.090M | 2.841M | 3.045M | 4.642M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | 3.473M | -36.58M | -3.399M | -1.539M | 1.199M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Operating Activities | -27.75M | -18.68M | -27.36M | -23.42M | 50.68M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | -1.229M | -0.7162M | -0.0423M | -1.429M | -0.2523M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Investments | 20.71M | 3.558M | 14.06M | -55.85M | -10.89M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Investing Activities | -1.984M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | 17.49M | 2.841M | 14.02M | -57.28M | -11.14M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Equity Issued | 0.289M | 0.434M | 0.1475M | 2.260M | 80.01M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Financing Activities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Cash from Financing Activities | 0.289M | 0.434M | 0.1475M | 2.260M | 80.01M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | 0.4067M | -0.0803M | -0.9368M | 0.148M | 0.2715M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Change in Cash & Cash Equivalents | -9.555M | -15.48M | -14.13M | -78.29M | 119.83M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 31.79M | 19.86M | 31.79M | 47.27M | 61.40M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 22.23M | 31.79M | 47.27M | 61.40M | 139.69M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
